Brief: Castle Biosciences Q4 Revenue USD 87.01 Million Vs. IBES Estimate USD 79 Million
26/02/2026 21:05
Feb 26 (Reuters) - Castle Biosciences Q4 net income USD -2.332 million. Q4 operating income USD -3.827 million Q4 operating expenses USD 90.837 million Q4 pretax profit USD -2.714 million
Recent news on Castle Biosciences
See all newsU.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Castle Biosciences beats Q1 revenue estimates, raises FY revenue outlook
Brief: Castle Biosciences Q1 Revenue USD 83.679 Million Vs. IBES Estimate USD 79.4 Million
Castle Biosciences Q4 revenue beats expectations
Brief: Castle Biosciences Q4 Revenue USD 87.01 Million Vs. IBES Estimate USD 79 Million